Alpha‐1‐antitrypsin inhibits acute liver failure in mice
Nils Jedicke, Nina Struever, Nupur Aggrawal, Tobias Welte, Michael P. Manns, Nisar P. Malek, Lars Zender, Sabina Janciauskiene, Torsten Wuestefeld – 21 January 2014 – Acute liver failure remains a critical clinical condition, with high mortality rates, and increased apoptosis of hepatocytes represents a key event in the cause of liver failure. Alpha‐1‐antitrypsin (AAT) is synthesized and secreted mainly by hepatocytes, and plasma purified AAT is used for augmentation therapy in patients with AAT deficiency.